VHL-mutated papillary cystadenoma of the mesosalpinx with omental tumor deposits and immunophenotypic overlap with mesothelioma.

Hum Pathol

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, 55905, USA. Electronic address:

Published: September 2024

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2024.06.011DOI Listing

Publication Analysis

Top Keywords

vhl-mutated papillary
4
papillary cystadenoma
4
cystadenoma mesosalpinx
4
mesosalpinx omental
4
omental tumor
4
tumor deposits
4
deposits immunophenotypic
4
immunophenotypic overlap
4
overlap mesothelioma
4
vhl-mutated
1

Similar Publications

Background: Biallelic von Hippel-Lindau (VHL) gene defects, a rate-limiting event in the carcinogenesis, occur in approximately 75% of sporadic clear-cell Renal Cell Carcinoma (RCC). We studied the VHL mutation status in a large population-based case group.

Methods: Cases were identified within the Netherlands cohort study on diet and cancer, which includes 120,852 men and women.

View Article and Find Full Text PDF

It has been documented that renal cell carcinomas (RCCs) occur frequently in patients treated with long-term dialysis, especially in cases of end-stage renal disease (ESRD)/acquired cystic disease of the kidney (ACDK). To address the molecular pathogenesis of ESRD/ACDK-associated RCCs, we examined 14 RCCs (7 clear-cell and 7 papillary carcinomas) in patients receiving dialysis for somatic mutations of the von Hippel-Lindau disease (VHL) gene as well as of the tyrosine kinase domain of the MET oncogene. Direct sequencing analyses revealed that three tumors exhibited VHL frameshifts (618delA, 386-395del10-bp, and 723-724insTC).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!